BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20005289)

  • 1. Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition.
    Wang C; Li S; Wang MW
    Toxicol In Vitro; 2010 Apr; 24(3):898-904. PubMed ID: 20005289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of protein kinase C on human melanoma A375-S2 cell death induced by evodiamine].
    Wang C; Wang MW; Tashiro S; Onodera S; Ikejima T
    Yao Xue Xue Bao; 2005 Nov; 40(11):1033-6. PubMed ID: 16499090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evodiamine induced human melanoma A375-S2 cell death partially through interleukin 1 mediated pathway.
    Wang C; Wang MW; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2005 Jun; 28(6):984-9. PubMed ID: 15930731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of SIRT1 and phosphoinositide 3-OH kinase/protein kinase C pathways in evodiamine-induced human melanoma A375-S2 cell death.
    Wang C; Wang MW; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2005 Apr; 97(4):494-500. PubMed ID: 15821341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracellular regulation of evodiamine-induced A375-S2 cell death.
    Zhang Y; Wu LJ; Tashiro S; Onodera S; Ikejima T
    Biol Pharm Bull; 2003 Nov; 26(11):1543-7. PubMed ID: 14600398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion.
    Takada Y; Kobayashi Y; Aggarwal BB
    J Biol Chem; 2005 Apr; 280(17):17203-12. PubMed ID: 15710601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evodiamine induces tumor cell death through different pathways: apoptosis and necrosis.
    Zhang Y; Wu LJ; Tashiro S; Onodera S; Ikejima T
    Acta Pharmacol Sin; 2004 Jan; 25(1):83-9. PubMed ID: 14704127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide activated by p38 and NF-kappaB facilitates apoptosis and cell cycle arrest under oxidative stress in evodiamine-treated human melanoma A375-S2 cells.
    Yang J; Wu LJ; Tashiro S; Onodera S; Ikejima T
    Free Radic Res; 2008 Jan; 42(1):1-11. PubMed ID: 18324518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evodiamine induces A375-S2 cell death through two different pathways].
    Zhang Y; Wu LJ; Tashiro S; Onodera S; Ikejima T
    Yao Xue Xue Bao; 2003 Sep; 38(9):650-3. PubMed ID: 14730911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway.
    Ho FM; Lin WW; Chen BC; Chao CM; Yang CR; Lin LY; Lai CC; Liu SH; Liau CS
    Cell Signal; 2006 Mar; 18(3):391-9. PubMed ID: 15970429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coactivation of the PI3K/Akt and ERK signaling pathways in PCB153-induced NF-κB activation and caspase inhibition.
    Liu C; Yang J; Fu W; Qi S; Wang C; Quan C; Yang K
    Toxicol Appl Pharmacol; 2014 Jun; 277(3):270-8. PubMed ID: 24726520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Critical roles of reactive oxygen species in mitochondrial permeability transition in mediating evodiamine-induced human melanoma A375-S2 cell apoptosis.
    Yang J; Wu LJ; Tashino S; Onodera S; Ikejima T
    Free Radic Res; 2007 Oct; 41(10):1099-108. PubMed ID: 17886031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-kappaB-dependent cell survival after serotonin 1A receptor activation.
    Hsiung SC; Tamir H; Franke TF; Liu KP
    J Neurochem; 2005 Dec; 95(6):1653-66. PubMed ID: 16238696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evodiamine as the Active Compound of Evodiae fructus to Inhibit Proliferation and Migration of Prostate Cancer through PI3K/AKT/NF-
    Lei Y; Chan M; Liu H; Lyu W; Chen L; Zhong Y; Gan H; Wang M; Qi M; Guo Y; Liu J; Zhang E
    Dis Markers; 2022; 2022():4399334. PubMed ID: 35899176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells.
    Fei XF; Wang BX; Li TJ; Tashiro S; Minami M; Xing DJ; Ikejima T
    Cancer Sci; 2003 Jan; 94(1):92-8. PubMed ID: 12708481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway.
    Siwak DR; Shishodia S; Aggarwal BB; Kurzrock R
    Cancer; 2005 Aug; 104(4):879-90. PubMed ID: 16007726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cantharidin impairs cell migration and invasion of A375.S2 human melanoma cells by suppressing MMP-2 and -9 through PI3K/NF-κB signaling pathways.
    Ji BC; Hsiao YP; Tsai CH; Chang SJ; Hsu SC; Liu HC; Huang YP; Lien JC; Chung JG
    Anticancer Res; 2015 Feb; 35(2):729-38. PubMed ID: 25667452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation.
    Liu Q; Kou JP; Yu BY
    Neurochem Int; 2011 Jan; 58(1):119-25. PubMed ID: 21078355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP.
    Kan SF; Huang WJ; Lin LC; Wang PS
    Int J Cancer; 2004 Jul; 110(5):641-51. PubMed ID: 15146552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnolol induces apoptosis via activation of both mitochondrial and death receptor pathways in A375-S2 cells.
    You Q; Li M; Jiao G
    Arch Pharm Res; 2009 Dec; 32(12):1789-94. PubMed ID: 20162409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.